Microglial Nox2 Plays a Key Role in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

Chih-Fen Hu1,2, San-Pin Wu3, Gu-Jiun Lin4

  • 1Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.

Insights

Phagocyte NADPH oxidase (Nox2) deficiency reduces central nervous system damage in a multiple sclerosis model. This suggests Nox2 inhibition could be a therapeutic target for multiple sclerosis (MS).

Area of Science:

  • Neuroimmunology
  • Oxidative Stress
  • Central Nervous System (CNS) Pathogenesis

Background:

  • Oxidative stress is implicated in multiple sclerosis (MS) pathogenesis.
  • The specific role of superoxide-producing phagocyte NADPH oxidase (Nox2) in the CNS during MS is not fully understood.

Purpose of the Study:

  • To investigate the impact of Nox2 gene ablation on immune responses and CNS pathology in a mouse model of experimental autoimmune encephalomyelitis (EAE).
  • To identify Nox2-dependent inflammatory pathways in microglia relevant to MS pathogenesis.

Main Methods:

  • Utilized a mouse experimental autoimmune encephalomyelitis (EAE) model.
  • Compared wild-type and Nox2-deficient (Nox2-/-) mice.
  • Analyzed cytokine and chemokine profiles, immune cell infiltration, demyelination, and oxidative stress in CNS tissues.
  • Performed RNA-sequencing (RNA-seq) on microglia and conducted gene ontology and pathway enrichment analyses.

Main Results:

  • Nox2 deficiency significantly attenuated EAE severity, reducing neural damage, immune cell infiltration, demyelination, and oxidative stress in the CNS.
  • Pro- and anti-inflammatory cytokine and chemokine levels, along with immune cell populations (autoreactive T cells, myeloid cells, microglia), were significantly lower in the CNS of Nox2-/- mice.
  • RNA-seq identified novel Nox2-dependent pro-inflammatory genes in microglia and revealed Nox2's regulatory role in key MS/EAE pathways.

Conclusions:

  • Microglial Nox2 plays a critical role in regulating neuroinflammation and CNS pathogenesis during EAE.
  • Nox2 deficiency confers protection against EAE, highlighting its pathogenic contribution.
  • Targeting Nox2 may represent a promising therapeutic strategy for managing multiple sclerosis.

Related Concept Videos